Ligand validation:6S0V

XXX: (1R,2R,3S,4R,6S)-4,6-diamino-2,3-dihydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside

XXX is a Ligand Of Interest in 6S0V designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6S0V_XXX_F_306	39%	45%	0.23	0.94	0.59	1.53	-	7	0	0	100%	0.7
6S0V_XXX_D_306	30%	38%	0.22	0.884	0.68	1.81	-	7	1	0	100%	0.7523
6S0V_XXX_E_305	22%	48%	0.273	0.887	0.65	1.35	-	4	2	0	100%	0.7
6S0V_XXX_B_304	14%	66%	0.306	0.856	0.35	0.93	-	3	2	0	100%	1
6S0V_XXX_C_304	12%	50%	0.295	0.829	0.74	1.2	1	4	1	0	100%	0.7045
6S0V_XXX_A_305	1%	46%	0.42	0.638	0.59	1.49	-	7	1	0	100%	1
7CL6_XXX_C_303	80%	66%	0.113	0.964	0.49	0.78	-	1	0	0	100%	1
5Z8K_XXX_A_502	61%	41%	0.122	0.91	1.23	1.11	2	3	0	0	100%	1
2ET8_XXX_B_51	51%	27%	0.197	0.954	1.87	1.21	7	4	1	0	100%	1
2FCX_XXX_A_101	37%	67%	0.161	0.859	0.43	0.83	-	2	0	0	100%	1
6E0D_XXX_A_502	8%	24%	0.33	0.806	1.09	2.19	2	10	3	0	100%	0.6

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.